Pseudotumor Cerebri: Yet Another Reason to Fight Obesity

Journal of Pediatric Health Care

Volumn 22, Issue 1, 2008, Pages 40-43

  Stevenson, Sharon B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DIURETIC AGENT; DRUG DERIVATIVE; FRUCTOSE; TOPIRAMATE;

ADOLESCENT; ARTICLE; BODY MASS; BRAIN PSEUDOTUMOR; CHILD; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HEADACHE; HUMAN; NURSE ATTITUDE; NURSE PRACTITIONER; NURSING ASSESSMENT; OBESITY; OPHTHALMOSCOPY; ORGANIZATION AND MANAGEMENT; PEDIATRIC NURSING; RISK FACTOR;

ACETAZOLAMIDE; ADOLESCENT; BODY MASS INDEX; CARBONIC ANHYDRASE INHIBITORS; CHILD; DIAGNOSIS, DIFFERENTIAL; DIURETICS; EARLY DIAGNOSIS; FRUCTOSE; HEADACHE; HUMANS; NURSE PRACTITIONERS; NURSE'S ROLE; NURSING ASSESSMENT; OBESITY; OPHTHALMOSCOPY; PEDIATRIC NURSING; PSEUDOTUMOR CEREBRI; RISK FACTORS;

EID: 37449002241     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2007.05.004     Document Type: Article

References (18)

1. Alore P., Jay W., and Macken M. Topiramate, pseudotumor cerebri, weight-loss and glaucoma: An ophthalmologic perspective. Seminars in Ophthalmology 21 (2006) 15-17
2. Carta A., Bertuzzi F., Cologno D., Giorgi C., Montanari E., and Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): Descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. European Journal of Ophthalmology 14 (2004) 48-54
3. Centers for Disease Control and Prevention, National Center for Health Statistics. (n.d.). Prevalence of overweight children and adolescents: United States, 2003-2004. Retrieved February 21, 2007, from http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overweight/overwght_child_03.htm.
4. Distelmaier F., Ulrike S., Messing-Juenger M., Assmann B., Mayatepek E., and Rosenbaum T. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain & Development 28 (2006) 190-195
5. Friedman D.I. Pseudotumor cerebri. Neurologic Clinics 22 (2004) 99-131
6. Friedman D.I., and Jacobson D.M. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59 (2002) 1492-1495
7. Giovannini, J., & Chrousos, G. (2005). Papilledema. Retrieved February 21, 2007, from http://www.emedicine.com/OPH/topic187.htm.
8. International Headache Society. (2004). Headache attributed to idiopathic intracranial hypertension (IIH). Retrieved February 21, 2007, from http://ihs-classification.org/en/02_klassifikation/03_teil2/07.01.01_nonvascular.html.
9. Kesler A., and Bassan H. Pseudotumor cerebri-idiopathic intracranial hypertension in the pediatric population. Pediatric Endocrinology Reviews (PER) 3 (2006) 387-392
10. Kesler A., and Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. Journal of Child Neurology 17 (2002) 745-747
11. Kesler A., and Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. Journal of Neuro-Ophthalmology 21 (2001) 12-14
12. Lehman C.A. Idiopathic intracranial hypertension within the ICF model: A review of the literature. Journal of Neuroscience Nursing 35 (2003) 263-270
13. Lexi-Comp Online-Microsoft Internet Explorer. Retrieved February 21, 2007, from http://www.crlonline.com/crlsql/servlet/crlonline.
14. Lueck C., and McIlwaine G. Interventions for idiopathic intracranial hypertension. The Cochrane Database of Systematic Reviews (2006)
15. Mathews M.K., Sergott R.C., and Savino P.J. Pseudotumor cerebri. Current Opinion in Ophthalmology 14 (2003) 364-370
16. Schexnayder L.K., and Chapman K. Presentation, investigation and management of idiopathic intracranial hypertension in children. Current Paediatrics 16 (2006) 336-342
17. Skau M., Brennum J., Gjerris F., and Jensen R. What is new about idiopathic intracranial hypertension?. An updated review of mechanism and treatment. Cephalalgia 26 (2006) 384-399
18. Uddin A.B.M. Drug-induced pseudotumor cerebri. Clinical Neuropharmacology 26 (2003) 236-238